{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:22:51Z","timestamp":1789086171480,"version":"build-2803163510"},"reference-count":55,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIH","award":["DE027329"],"award-info":[{"award-number":["DE027329"]}]},{"name":"NIH","award":["DE028420"],"award-info":[{"award-number":["DE028420"]}]},{"name":"NIH","award":["DE24371"],"award-info":[{"award-number":["DE24371"]}]},{"name":"NIH","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}]},{"name":"NIH","award":["P50CA261605"],"award-info":[{"award-number":["P50CA261605"]}]},{"name":"NIH","award":["RRID:SCR_021985"],"award-info":[{"award-number":["RRID:SCR_021985"]}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["IRG 16-184-56"],"award-info":[{"award-number":["IRG 16-184-56"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VA","award":["I01 BX003232"],"award-info":[{"award-number":["I01 BX003232"]}]},{"name":"VA","award":["IK6BX005962"],"award-info":[{"award-number":["IK6BX005962"]}]},{"DOI":"10.13039\/100009141","name":"Cancer League of Colorado","doi-asserted-by":"publisher","award":["AWD-163274-CY"],"award-info":[{"award-number":["AWD-163274-CY"]}],"id":[{"id":"10.13039\/100009141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2023,8,23]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oral squamous cell carcinoma (OSCC) is a devastating disease most often associated with tobacco consumption that induces a field of mutations from which a tumor arises. Identification of ways to prevent the emergence of cancer in high-risk patients is an ultimate goal for combatting all types of cancer, including OSCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our study employs a mouse model of tongue carcinogenesis induced by tobacco carcinogen mimetic, 4-nitroquinoline 1-oxide (4NQO), to establish tongue dysplasia and OSCC. We use conventional histology, immunohistochemistry, multispectral imaging, mass cytometry, novel cell lines, pharmaceutical inhibition of PI3K\u03b3, T-cell suppression assays and mouse transplant models in our functional experimentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In our study, we identify Ly6G+ granulocytes as the most abundant immune cell type in a model of tongue carcinogenesis induced by tobacco carcinogen mimetic 4NQO. Targeting Ly6G+ granulocytes with a pharmacologic inhibitor of PI3K\u03b3, an isoform of PI3K exclusively expressed by myeloid cells, resulted in reduced tongue dysplasia severity, and reduced rates of OSCC. Importantly, we performed functional assays with the Ly6G+ granulocytes induced in cell line models of 4NQO carcinogenesis to demonstrate that these granulocytes have increased polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) activity against T-cell proliferation and these PMN-MDSCs play a functional role in promoting tumor formation by inhibiting tumor regression in a PI3K\u03b3-dependent manner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, our data suggest that recruitment of PMN-MDSCs to sites of dysplasia is critical to immune suppression of CD8 T cells, thereby permitting malignancy, and PI3K\u03b3 inhibitors are one mechanism to reduce PMN-MDSC recruitment, immunosuppression and tumorigenesis in OSCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2023-007110","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T12:36:04Z","timestamp":1695299764000},"page":"e007110","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03692325","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Khoa A","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa N","family":"DePledge","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bian","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Pathology & Laboratory Medicine, University of California Davis, Davis, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Von","family":"Samedi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber A","family":"Berning","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Owens","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Pathology & Laboratory Medicine, University of California Davis, Davis, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-488X","authenticated-orcid":false,"given":"Christian D","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"2025100311070625000_11.9.e007110.1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31937"},{"key":"2025100311070625000_11.9.e007110.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"2025100311070625000_11.9.e007110.3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025100311070625000_11.9.e007110.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7"},{"key":"2025100311070625000_11.9.e007110.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1602252"},{"key":"2025100311070625000_11.9.e007110.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30421-7"},{"key":"2025100311070625000_11.9.e007110.7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/jomfp.JOMFP_13_19","article-title":"Oral epithelial dysplasia: classifications and clinical relevance in risk assessment of oral potentially malignant disorders","volume":"23","author":"Ranganathan","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"2025100311070625000_11.9.e007110.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217"},{"key":"2025100311070625000_11.9.e007110.9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ijc.33876","article-title":"Treatment outcomes and survival following definitive (Chemo)Radiotherapy in HPV-positive oropharynx cancer: large-scale comparison of DAHANCA vs PMH cohorts","volume":"150","author":"Lassen","year":"2022","journal-title":"Int J Cancer"},{"key":"2025100311070625000_11.9.e007110.10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hed.26006","article-title":"Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype","volume":"42","author":"Iocca","year":"2020","journal-title":"Head & Neck"},{"key":"2025100311070625000_11.9.e007110.11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jop.12726","article-title":"Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis","volume":"47","author":"Mello","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"2025100311070625000_11.9.e007110.12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239"},{"key":"2025100311070625000_11.9.e007110.13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0367"},{"key":"2025100311070625000_11.9.e007110.14","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000230","article-title":"An inflammatory cytokine milieu is prominent in Premalignant oral lesions, but subsides when lesions progress to squamous cell carcinoma","volume":"5","author":"Woodford","year":"2014","journal-title":"J Clin Cell Immunol"},{"key":"2025100311070625000_11.9.e007110.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2014.01.004"},{"key":"2025100311070625000_11.9.e007110.16","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-17-0108"},{"key":"2025100311070625000_11.9.e007110.17","doi-asserted-by":"crossref","DOI":"10.1038\/nature21026","article-title":"Corrigendum: Pi3K\u03b3 is a molecular switch that controls immune suppression","volume":"542","author":"Kaneda","year":"2017","journal-title":"Nature"},{"key":"2025100311070625000_11.9.e007110.18","doi-asserted-by":"publisher","DOI":"10.1038\/nature20554"},{"key":"2025100311070625000_11.9.e007110.19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0999-3"},{"key":"2025100311070625000_11.9.e007110.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13471-0"},{"key":"2025100311070625000_11.9.e007110.21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081835","article-title":"Simultaneous expression of Th1- and Treg-associated Chemokine genes and Cd4(+), Cd8(+), and Foxp3(+) cells in the Premalignant lesions of 4Nqo-induced Mouse tongue tumorigenesis","volume":"13","author":"Yamaguchi","year":"2021","journal-title":"Cancers"},{"key":"2025100311070625000_11.9.e007110.22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19401-9","article-title":"Genomic landscape and Clonal architecture of Mouse oral squamous cell Carcinomas dictate tumour Ecology","volume":"11","author":"Sequeira","year":"2020","journal-title":"Nat Commun"},{"key":"2025100311070625000_11.9.e007110.23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.741013","article-title":"Tnfalpha signaling is increased in progressing oral potentially malignant disorders and regulates malignant transformation in an oral carcinogenesis model","volume":"11","author":"Chadwick","year":"2021","journal-title":"Front Oncol"},{"key":"2025100311070625000_11.9.e007110.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099648"},{"key":"2025100311070625000_11.9.e007110.25","doi-asserted-by":"publisher","DOI":"10.1038\/nri3175"},{"key":"2025100311070625000_11.9.e007110.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.029"},{"key":"2025100311070625000_11.9.e007110.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00209-1"},{"key":"2025100311070625000_11.9.e007110.28","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00238"},{"key":"2025100311070625000_11.9.e007110.29","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0502"},{"key":"2025100311070625000_11.9.e007110.30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65856"},{"key":"2025100311070625000_11.9.e007110.31","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02522-2","article-title":"Distinct immune Microenvironment profiles of therapeutic responders emerge in combined Tgfbeta\/PD-L1 blockade-treated squamous cell carcinoma","volume":"4","author":"Strait","year":"2021","journal-title":"Commun Biol"},{"key":"2025100311070625000_11.9.e007110.32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived Suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"2025100311070625000_11.9.e007110.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1154-8"},{"key":"2025100311070625000_11.9.e007110.34","first-page":"3","article-title":"Histological and Immunochemical studies of oral Leukoplakia: phenotype and distribution of immunocompetent cells","volume":"47","author":"Bondad-Palmario","year":"1995","journal-title":"J Philipp Dent Assoc"},{"key":"2025100311070625000_11.9.e007110.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1587-0","article-title":"Tumor-associated Macrophages in oral Premalignant lesions Coexpress Cd163 and Stat1 in a Th1-dominated Microenvironment","volume":"15","author":"Mori","year":"2015","journal-title":"BMC Cancer"},{"key":"2025100311070625000_11.9.e007110.36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/apm.12881","article-title":"Cd8+ and Cd163+ infiltrating cells and PD-L1 Immunoexpression in oral Leukoplakia and oral carcinoma","volume":"126","author":"Stasikowska-Kanicka","year":"2018","journal-title":"APMIS"},{"key":"2025100311070625000_11.9.e007110.37","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/ijc.30543","article-title":"Transient immunological and clinical effectiveness of treating mice bearing Premalignant oral lesions with PD-1 antibodies","volume":"140","author":"Levingston","year":"2017","journal-title":"Int J Cancer"},{"key":"2025100311070625000_11.9.e007110.38","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0607"},{"key":"2025100311070625000_11.9.e007110.39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1601-0825.2011.01846.x","article-title":"Myeloid-derived Suppressor cells contribute to oral cancer progression in 4Nqo-treated mice","volume":"18","author":"Chu","year":"2012","journal-title":"Oral Dis"},{"key":"2025100311070625000_11.9.e007110.40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.270"},{"key":"2025100311070625000_11.9.e007110.41","unstructured":"Infinity receives fast track designation for Eganelisib in combination with a Checkpoint inhibitor and chemotherapy for first-line treatment of advanced TNBC.;Press release September 29, 2020. n.d. Available: https:\/\/bit.ly\/3imQjYR"},{"key":"2025100311070625000_11.9.e007110.42","unstructured":"FDA grants IPI-549 and Nivolumab combo fast track designation for urothelial cancer. press release March 25, 2020. n.d. Available: https:\/\/www.targetedonc.com\/view\/sequential-mitomycin-with-bcg-is-shown-to-be-safe-in-high-risk-nmibc"},{"key":"2025100311070625000_11.9.e007110.43","doi-asserted-by":"crossref","unstructured":"Berta GN , Di Scipio F , Yang Z , et al . n.d. Chemical oral Cancerogenesis is impaired in Pi3Kgamma knockout and kinase-dead mice. Cancers;13:4211. doi:10.3390\/cancers13164211","DOI":"10.3390\/cancers13164211"},{"key":"2025100311070625000_11.9.e007110.44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/jcm10132872","article-title":"MDSC in mice and men: mechanisms of immunosuppression in cancer","volume":"10","author":"Vanhaver","year":"2021","journal-title":"J Clin Med"},{"key":"2025100311070625000_11.9.e007110.45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2587"},{"key":"2025100311070625000_11.9.e007110.46","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0569"},{"key":"2025100311070625000_11.9.e007110.47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0902280106"},{"key":"2025100311070625000_11.9.e007110.48","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1494113","article-title":"Prognostic role of pretreatment circulating Mdscs in patients with solid malignancies: A meta-analysis of 40 studies","volume":"7","author":"Wang","year":"2018","journal-title":"Oncoimmunology"},{"key":"2025100311070625000_11.9.e007110.49","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-009-0634-0"},{"key":"2025100311070625000_11.9.e007110.50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900092"},{"key":"2025100311070625000_11.9.e007110.51","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived Suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"OncoImmunology"},{"key":"2025100311070625000_11.9.e007110.52","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0676"},{"key":"2025100311070625000_11.9.e007110.53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56218-z","article-title":"Exploring the Prognostic value of the neutrophil-to-lymphocyte ratio in cancer","volume":"9","author":"Howard","year":"2019","journal-title":"Sci Rep"},{"key":"2025100311070625000_11.9.e007110.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07063-1","article-title":"Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study","volume":"20","author":"Hasegawa","year":"2020","journal-title":"BMC Cancer"},{"key":"2025100311070625000_11.9.e007110.55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/IJPM.IJPM_114_20","article-title":"Diagnostic efficacy of neutrophil to lymphocyte ratio (NLR) in oral potentially malignant disorders and oral cancer","volume":"64","author":"Singh","year":"2021","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-007110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:07:19Z","timestamp":1759514839000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-007110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,21]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/jitc-2023-007110"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-007110","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}